Keith Harshman

16.1k citations

43 papers · 5.0k indexed · 1 hit paper · h-index 26

Oncology top 1%
Cancer Research top 2%
- MicroRNA in disease regulation 3
Molecular Biology top 2%
- Gene expression and cancer classification 4
- Melanoma and MAPK Pathways 3
- Viral Infectious Diseases and Gene Expression in Insects 3
- Molecular Biology Techniques and Applications 3
Aging top 5%
Cell Biology top 2%
Genetics
- Virus-based gene therapy research 3
Epidemiology
- Nail Diseases and Treatments 3
Immunology
- Immunotherapy and Immune Responses 3

Co-authors: Mark H. Skolnick Sean V. Tavtigian Alexander Kamb Elisabeth Stockert Rufus S. Day Nelleke A. Gruis Bruce E. Johnson Qingyun Liu
Cited by: Oncology Cancer Research Molecular Biology
Journals: Nucleic Acids Research (5 papers)Science (2 papers)Eukaryotic Cell (2 papers)
Partner nations: Switzerland United States Spain

In The Last Decade

Keith Harshman

43 papers receiving 4.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Keith Harshman

Since Specialization

Citations

This map shows the geographic impact of Keith Harshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Harshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Harshman more than expected).

Fields of papers citing papers by Keith Harshman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Harshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Harshman. The network helps show where Keith Harshman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Keith Harshman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Keith Harshman Line = papers co-authored together Keith Harshman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Identification and molecular characterisation of Lausanne Institutional Biobank participants with familial hypercholesterolaemia – a proof-of-concept study Swiss Medical Weekly ·Fabienne Maurer,Sylvain Pradervand,Isabelle Guilleret,David Nanchen,Ibrahim Zughayer,Laurence Chapatte,Karolina Bojkowska,Zahurul A. Bhuiyan,Dina Ezzat,Keith Harshman,Vincent Mooser	2016	6
2	Genome-wide re-sequencing of multidrug-resistant Mycobacterium leprae Airaku-3 Clinical Microbiology and Infection ·Pushpendra Singh,Andrej Benjak,寛樹池永,M. Kai,Philippe Busso,Charlotte Avanzi,Alberto Paniz‐Mondolfi,Deyu Song,Keith Harshman,Jacques Rougemont,Masao Matsuoka,Stewart T. Cole	2014	10
3	Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression Clinical Cancer Research ·Emanuela Romano,Sylvain Pradervand,Alexandra Paillusson,Johann Weber,Keith Harshman,Katja Muehlethaler,Daniel E. Speiser,Solange Peters,Donata Rimoldi,Olivier Michielin	2013	96
4	Coexistence of multiple escape mechanisms in a BRAF^V600E-mutated cutaneous melanoma treated with vemurafenib. Journal of Clinical Oncology ·Olivier Michielin,Emanuela Romano,Solange Peters,Alexandra Paillusson,Johann Weber,Jaime E. ORDUY,Keith Harshman,Daniel E. Speiser,Sylvain Pradervand,Donata Rimoldi	2013	2
5	Exome sequencing identifies recurrent somatic MAP2K1 and MAP2K2 mutations in melanoma Nature Genetics ·Sergey I. Nikolaev,Donata Rimoldi,Christian Iseli,Armand Valsesia,Daniel Robyr,Corinne Gehrig,Keith Harshman,Michel Guipponi,Olesya V. Bukach,Vincent Zoete,Olivier Michielin,Katja Muehlethaler,Daniel E. Speiser,J. Beckmann,Ioannis Xénarios,Thanos D. Halazonetis,C. Victor Jongeneel,Brian J. Stevenson,Stylianos E. Antonarakis	2011	295
6	Substantial deletion overlap among divergent Arabidopsis genomes revealed by intersection of short reads and tiling arrays Genome biology ·Luca Santuari,Sylvain Pradervand,Jay Layer,Jérôme Thomas,Eavan Dorcey,Keith Harshman,Ioannis Xénarios,Thomas Juenger,Christian S. Hardtke	2010	25
7	Impact of normalization on miRNA microarray expression profiling RNA ·Sylvain Pradervand,Johann Weber,Jérôme Thomas,Manuel Bueno Sánchez,Pratyaksha Wirapati,Karine Lefort,G. Paolo Dotto,Keith Harshman	2009	143
8	Comprehensive analysis of Arabidopsis expression level polymorphisms with simple inheritance Molecular Systems Biology ·Muhamad Faizzuddin Mohd Razali,Johann Weber,Daniel R. Goldstein,Georg Zeller,野村茂広,Jérôme Thomas,Detlef Weigel,Keith Harshman,Christian S. Hardtke	2009	16
9	c-Cbl expression levels regulate the functional responses of human central and effector memory CD4 T cells Blood ·Nicolò Costantino Brembilla,Johann Weber,Donata Rimoldi,Sylvain Pradervand,Frédéric Schütz,Giuseppe Pantaleo,Curzio Rüegg,Manfredo Quadroni,Keith Harshman,Marie‐Agnès Doucey	2008	10
10	Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells Gut ·K Happel,Juan José Lozano,Elisabeth Castellanos,Luis A. López‐Fernández,Keith Harshman,Carlos Martı́nez-A,Ofelia Alvarado Morales,Timothy M. Thomson,Rosanna Paciucci	2007	21
11	RACE: Remote Analysis Computation for gene Expression data Nucleic Acids Research ·R. A. LaBoube,Steffen Heber,Mirjam Sick,Lizzi Valeria Martínez-Martínez,Keith Harshman,Beate Sick	2005	52
12	ZAP-70 upregulation in transformed B cells after early pre-BI cell transplant into NOD/SCID mice Oncogene ·Antonio Ruiz‐Vela,Raquel Piqueras,Carla Eponina Carvalho-Pinto,Lucio Gómez,Elisa Yaniz‐Galende,Takenori Aiyama,António Bernad,Keith Harshman,Carlos Martı́nez-A	2005	4
13	Microarray Analysis Reveals Characteristic Changes of Host Cell Gene Expression in Response to Attenuated Modified Vaccinia Virus Ankara Infection of Human HeLa Cells Journal of Virology ·Susana Guerra,Luis A. López‐Fernández,Raquel Conde-Álvarez,Alberto Pascual-Montano,Keith Harshman,Mariano Estéban	2004	71
14	Genetic mapping of the Brca1 gene on mouse Chromosome 11 Mammalian Genome ·Laura De Gregorio,Keith Harshman,Judith Rosenthal,Tommaso A. Dragani,Marco A. Pierotti	1996	1
15	Localization of the VHR Phosphatase Gene and Its Analysis as a Candidate for BRCA1 Genomics ·Alexander Kamb,P. Andrew Futreal,Judith Rosenthal,Charles Cochran,Keith Harshman,Qingyun Liu,Lynn Catterson,Sean V. Tavtigian,Thanh V. Tran,Charles E. Hussey,Russell Bell,Yoshio Miki,Jeffrey Swensen,Maurine R. Hobbs,Jeff Marks,L. Michelle Bennett,J. Carl Barrett,Roger W. Wiseman,Donna Shattuck-Eidens	1994	10
16	Conserved cysteine residues of Oct-2 POU domain confer sensitivity to oxidation but are dispensable for sequence-specific DNA binding Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression ·Hamed Taghipour Farshi,敦子繁沢,Keith Harshman,Ifeanyi Seteyeobot,David N. Arnosti	1993	11
17	Anti-IgM antibodies down modulate mu-enhancer activity and OTF2 levels in LPS-stimuulated mouse splenic B-cells Nucleic Acids Research ·Chandler Hh,Richard H. Scheuermann,Thomas Wirth,Thomas Gerster,V N Mirsoyanov,Keith Harshman,Christoph Berger	1991	12
18	Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins Nucleic Acids Research ·Edgar Schreiber,Keith Harshman,Iris Kemler,Ursula Malipiero,Walter Schaffner,A. Fontana	1990	142
19	Transcriptional activation by the SV40 AP-1 recognition element in yeast is mediated by a factor similar to AP-1 that is distinct from GCN4 Cell ·Keith Harshman,W. Scott Moye‐Rowley,Carl S. Parker	1988	216
20	YAP1 Encodes a Yeast Homolog of Mammalian Transcription Factor AP-1 Cold Spring Harbor Symposia on Quantitative Biology ·W. Scott Moye‐Rowley,Keith Harshman,C S Parker	1988	17

About Keith Harshman

Keith Harshman is a scholar working on Virology, Cancer Research and Molecular Biology, having authored 43 papers that have together received 5.0k indexed citations. Recurring topics across this work include Gene expression and cancer classification (4 papers), Virus-based gene therapy research (3 papers), Nail Diseases and Treatments (3 papers), MicroRNA in disease regulation (3 papers), Melanoma and MAPK Pathways (3 papers), Immunotherapy and Immune Responses (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers) and Molecular Biology Techniques and Applications (3 papers). The work is most often cited by research in Oncology (1.9k citations), Cancer Research (906 citations) and Molecular Biology (3.2k citations). Keith Harshman has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Mark H. Skolnick, Sean V. Tavtigian, Alexander Kamb, Elisabeth Stockert, Rufus S. Day, Nelleke A. Gruis, Bruce E. Johnson, Qingyun Liu, Jane Weaver-Feldhaus and W. Scott Moye‐Rowley. Their work appears in journals such as Nucleic Acids Research, Science, Eukaryotic Cell, BioTechniques and Journal of Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact